Cargando…

Amoxicillin/clavulanic-acid/dexamethasone/piperacillin/tazobactam: Lack of efficacy during off-label treatment of COVID-19 pneumonia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813469/ http://dx.doi.org/10.1007/s40278-022-09567-0

Ejemplares similares

Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Publicado: (2021)

Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
por: Drost, Sarah A., et al.
Publicado: (2023)

Amoxicillin/clavulanic-acid/dexamethasone: Vascular graft infection and off-label use: case report
Publicado: (2022)

Amoxicillin/clavulanic-acid/clarithromycin/dexamethasone: Fonsecaea associated cerebral phaeohyphomycosis following off label use of dexamethasone: case report
Publicado: (2022)

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
por: Schaper, N. C., et al.
Publicado: (2012)

598. In Vitro Activity of Aztreonam in Combination with Ceftazidime–Avibactam, Amoxicillin–Clavulanate, and Piperacillin–Tazobactam vs. NDM-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates
por: Walkty, Andrew, et al.
Publicado: (2019)

Amoxicillin/clavulanic-acid/prednisolone: Drug-induced cholestasis and lack of efficacy: case report
Publicado: (2021)

Amoxicillin/clavulanic-acid/tozinameran: Vulvar Aphthous ulcer and lack of efficacy: case report
Publicado: (2022)

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections
por: Gyssens, Inge C., et al.
Publicado: (2011)

Piperacillin/tazobactam: Eosinophilic-pneumonia: case report
Publicado: (2021)

Piperacillin/tazobactam/tocilizumab: Trichosporon asahii infection and off-label-use: case report
Publicado: (2021)

Myoclonus induced by amoxicillin-clavulanic acid
por: Viloria-Alebesque, Alejandro, et al.
Publicado: (2020)

Piperacillin/tazobactam: Acute eosinophilic pneumonia: case report
Publicado: (2021)

Is the standard dose of amoxicillin-clavulanic acid sufficient?
por: Haeseker, Michiel, et al.
Publicado: (2014)

Kounis syndrome associated with amoxicillin/clavulanic acid
por: Shimi, A, et al.
Publicado: (2016)

Amoxicillin/clavulanic acid-induced pancreatitis: case report
por: Chams, Sana, et al.
Publicado: (2018)

Amoxicillin/clavulanic acid: Aseptic meningitis: case report
Publicado: (2021)

Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
por: Yang, Jihyun, et al.
Publicado: (2023)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Methylprednisolone/piperacillin/tazobactam: Off-label use and methicillin-sensitive Staphylococcus aureus (MSSA) infection: case report
Publicado: (2021)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Amoxicillin-Clavulanate-Induced Ischaemic Colitis
por: Alonge, Marco, et al.
Publicado: (2020)

Amoxicillin/clavulanic-acid/azithromycin/lopinavir/ritonavir: Treatment failure following off label use and drug exposure during third trimester of pregnancy: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion
por: Fawaz, Sarah, et al.
Publicado: (2020)

Severe Case of Cholestatic Hepatitis From Amoxicillin/Clavulanic Acid
por: Goyal, Lokesh, et al.
Publicado: (2022)

Inclusion of clavulanic acid determinants in the basophil activation test improves the evaluation of immediate reactions to amoxicillin-clavulanic acid
por: Fernandez, Tahia D, et al.
Publicado: (2014)

Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate
por: BARIŞ KUZU, Ufuk, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ncb109egp3fbhh86t2hp6jj4uu